Search clinical trials for: multiple tyrosine kinase inhibitor(mTKI) Combined with anti-PD-1 antibody
Total 442 results
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalWithdrawnHepatocellular CarcinomaChina
-
XIANG YANQUNActive, not recruitingChemotherapy Effect | Metastatic Nasopharyngeal CarcinomaChina
-
Sun Yat-sen UniversityNot yet recruiting
-
Lee's Pharmaceutical LimitedRecruitingExtensive Stage Small Cell Lung CancerChina
-
Hunan Cancer HospitalSuzhou Sheng Diya Biomedical Co., Ltd.Active, not recruitingAdenocarcinoma of the LungChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Genentech, Inc.; Pharmacyclics LLC.RecruitingNon-Hodgkin's Lymphoma | Indolent Non-hodgkin Lymphoma | Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage II Nodal Marginal Zone Lymphoma | Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma | Ann Arbor... and other conditionsUnited States
-
Fudan UniversityRecruitingEsophageal Squamous Cell Carcinoma | Oligometastatic Disease | RadiotherapyChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
AVEO Pharmaceuticals, Inc.Bristol-Myers SquibbCompletedCarcinoma, Renal CellFrance
-
Jennifer WoyachActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Shanghai Jiao Tong University School of MedicineCompletedOral Cancer | VEGFR2 Inhibitor | Programmed Cell Death 1 Inhibitor | Inductive TherapyChina
-
Robert L. Ferris, MD, PhDBristol-Myers SquibbRecruitingHead and Neck Squamous Cell Carcinoma (HNSCC)United States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMantle Cell Lymphoma | Liver LymphomaUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedRecurrent IDHwt Gliomas With FGFR3-TACC3 Fusion | Recurrent IDHwt Gliomas With FGFR1-TACC1 FusionFrance
-
Fudan UniversityRecruiting
-
Qilu Hospital of Shandong UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruitingSmall Cell Lung Cancer
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Not yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
PfizerCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
Institute of Hematology & Blood Diseases HospitalRecruitingRefractory Hodgkin Lymphoma | Relapse | Hodgkin Lymphoma, AdultChina
-
Wen TianfuRecruitingAdvanced Hepatocellular CarcinomaChina
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Childhood Ependymoma | Advanced Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Puerto Rico
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Tianjin Medical University Cancer Institute and...Tianjin Medical University General Hospital; Tianjin Chest HospitalCompletedDelirium | Analgesia | NSCLC | ImmunotherapyChina
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
Han weidongUnknownMalignancies MultipleChina
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell LymphomaUnited States
-
Guangzhou Medical UniversityRecruiting
-
Jacobio Pharmaceuticals Co., Ltd.Merck Sharp & Dohme LLCRecruiting
-
Fudan UniversityAnyang Tumor HospitalNot yet recruiting
-
Anwita BiosciencesShanghai Junshi Bioscience Co., Ltd.RecruitingLymphoma | Solid Tumor, Adult | Neoplasm Malignant | Neoplasm, ExperimentalTaiwan
-
Chinese PLA General HospitalCompleted
-
Roswell Park Cancer InstituteWithdrawnMalignant Solid Neoplasm | Lung Adenocarcinoma | Colorectal Carcinoma | Pancreatic CarcinomaUnited States
-
University Hospital, Basel, SwitzerlandGMP network of BaselCompletedAdvanced MelanomaSwitzerland
-
The Fourth Affiliated Hospital of Zhejiang University...RecruitingAdvanced Solid TumorChina
-
Tongji HospitalThe Second Affiliated Hospital of Fujian Medical University; Geneplus-Beijing... and other collaboratorsRecruitingHepatocellular Carcinoma Non-resectableChina
-
Brian JonasNational Cancer Institute (NCI); Pharmacyclics LLC.RecruitingPhiladelphia Chromosome Positive | Adult B Acute Lymphoblastic LeukemiaUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer
-
Genentech, Inc.Completed
-
Northwestern UniversityNational Cancer Institute (NCI); PfizerTerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Breast Carcinoma Metastatic in the BrainUnited States
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central HospitalWithdrawnHepatocellular CarcinomaChina
-
Eisai Inc.Merck Sharp & Dohme LLCActive, not recruitingRenal Cell CarcinomaSpain, Canada, Portugal, Korea, Republic of, Taiwan, United States, Netherlands, United Kingdom, Czechia, Italy, Finland, Greece, Romania, Australia, Poland, Russian Federation
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | KRAS Gene Mutation | Metastatic Malignant Solid Neoplasm | EGFR Gene Mutation | ERBB2 Gene Amplification | ERBB2 Gene Mutation | EGFR Gene Amplification | ERBB3 Gene Mutation | ERBB4 Gene MutationUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Recurrent Acute Biphenotypic Leukemia | Blasts 20 Percent or More of Bone Marrow Nucleated Cells | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk...United States
-
Chinese PLA General HospitalZhejiang UniversityRecruitingLymphoma | Solid Tumor, Adult | EphA2 Overexpression | TP53 R273H | TP53 R175H | TP53 R248Q | TP53 R249SChina
-
Chinese PLA General HospitalZhejiang UniversityRecruitingSolid Tumor, Adult | KRAS G12D | EphA2 Overexpression | KRAS G12V | KRAS G12CChina
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer
-
University Hospital, LilleINSERM U1189 ONCOTHAIRecruitingMalignant Pleural Mesothelioma | Mesotheliomas PleuralFrance